Lloyd Mackenzie is a biopharmaceutical Research and Development executive with over 25 years of experience and expertise in drug development, lead candidate identification, biochemistry, medicinal chemistry, chemistry, manufacturing and control (CMC), quality assurance, clinical development, and operations. He has provided strategic leadership, oversight, planning, and execution across all aspects of drug development — from discovery, through to late-stage, global clinical trials, and across multiple therapeutic areas including oncology, inflammatory diseases, and pain. Mr. Mackenzie is an author on 4 patents and 16 scientific publications. He currently holds the position of Chief Operating Officer at NervGen Pharma, with prior executive-level positions at Notable Labs and Aquinox Pharmaceuticals.
